Small and medium-sized biotech companies
Statistics report about small and medium-sized innovative biotech companies
This report presents key facts and figures on small and mid-sized biotech companies which are the key driver of innovation for the whole biopharma sector. Small and mid-sized enterprises (SMEs) are responsible for most of the new breakthrough therapies and technologies. This report provides a good introduction into the biotech SME landscape, thereby focusing on two SMEs which made it to the big scene due to their COVID-19 vaccines: BioNTech and Moderna.
Report Details
Small and medium-sized biotech companies
Pages
44 Pages
Format
PPTX
,
PDF
Language
English
Released
2021
Access
Download from this page
Price
Old price: $495 USD New price: $345 USD
Comprehensive data insights
Includes all relevant statistics
Compiled by our industry experts
Table of contents
Biotech market
6
Basic
Statistic
Percentage of global pharmaceutical sales by technology 2016-2030
Premium
Statistic
Global biotech drug sales estimate 2012-2024
Premium
Statistic
Major pharma and biotech drug launches in 2026, by revenue estimates for 2032
Basic
Statistic
Enterprise value change in biopharma subsectors worldwide 2025-2026
Basic
Statistic
Sales per employee of select U.S. biotech and drug companies Q3-Q4 2025
Premium
Statistic
Gross profit margin of select U.S. biotech and drug companies Q1-Q4 2025
SME financing
6
Basic
Statistic
Total raised capital in U.S. and Europe biotechnology industry 2015-2024
Premium
Statistic
IPOs in U.S. and Europe biotechnology industry 2015-2024
Basic
Statistic
Venture capital in U.S. and Europe biotechnology industry 2015-2024
Basic
Statistic
United States biotech financing data 2015-2020
Premium
Statistic
Value of top U.S. biotech IPOs 2024
Basic
Statistic
U.S. investment for emerging therapeutic companies 2011-2023
Research & development
5
Basic
Statistic
Leading 50 global pharmaceutical and biotech companies 2024, by R&D intensity
Basic
Statistic
Number of FDA approved NMEs, 2009-2018, by size of drug owner
Basic
Statistic
Number of FDA approved NMEs, 2009-2018, by size of drug originator
Basic
Statistic
Origin of new drugs licensed or acquired, 2014-2018, by company size
Basic
Statistic
Alliances U.S. and Europe biotech companies by total potential value 2024
Growth
4
Premium
Statistic
Top performing companies on Nasdaq Biotech Index 2020
Basic
Statistic
Major pharmaceutical and biotech companies in 2024, by operating profit growth
Premium
Statistic
Major pharmaceutical companies 2024, by capex growth
Basic
Statistic
Major pharmaceutical companies in R&D spending growth in 2024
BioNTech vs. Moderna
8
Basic
Statistic
Revenue of BioNTech 2017-2025
Basic
Statistic
Moderna's revenue 2016-2025
Basic
Statistic
Operating income of BioNTech 2017-2024
Basic
Statistic
Moderna net income 2016-2024
Basic
Statistic
BioNTech total assets 2017-2025
Basic
Statistic
Moderna total assets 2016-2024
Basic
Statistic
R&D expenses of BioNTech 2017-2025
Basic
Statistic
R&D expenses of Moderna 2016-2024
Comparison of COVID-19 vaccines
5
Basic
Statistic
Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
Basic
Statistic
COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
Basic
Statistic
COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
Premium
Statistic
BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
Basic
Statistic
Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver
FURTHER REPORTS
Recommended and recent reports
Recommended statistics
You may also be interested in...